BMS-538305 HCl

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 525500

CAS#: 841302-51-0 (HCl)

Description: BMS-538305 is a potent and selective dipeptidyl peptidase IV (DPP-IV) inhibitor.


Chemical Structure

img
BMS-538305 HCl
CAS# 841302-51-0 (HCl)

Theoretical Analysis

MedKoo Cat#: 525500
Name: BMS-538305 HCl
CAS#: 841302-51-0 (HCl)
Chemical Formula: C17H27ClN2O2
Exact Mass: 0.00
Molecular Weight: 326.865
Elemental Analysis: C, 62.47; H, 8.33; Cl, 10.85; N, 8.57; O, 9.79

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 841302-51-0 (HCl)   841302-20-3 (free base)    

Synonym: BMS-538305; BMS 538305; BMS538305; BMS-538305 HCl; BMS-538305 hydrochloride;

IUPAC/Chemical Name: 2-Azabicyclo[3.1.0]hexane, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, monohydrochloride, (1S,5R)-

InChi Key: LQQSFVABLOCZDJ-VKDPJJMISA-N

InChi Code: InChI=1S/C17H26N2O2.ClH/c18-14(15(20)19-2-1-12-4-13(12)19)16-5-10-3-11(6-16)8-17(21,7-10)9-16;/h10-14,21H,1-9,18H2;1H/t10?,11?,12-,13+,14-,16?,17?;/m1./s1

SMILES Code: O=C([C@H](C12CC(CC(C2)C3)CC3(O)C1)N)N4[C@]5(C[C@]5(CC4)[H])[H].[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 326.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Das S, Goswami RK. Total synthesis of marine natural products separacenes A and B. Org Biomol Chem. 2017 May 23. doi: 10.1039/c7ob00345e. [Epub ahead of print] PubMed PMID: 28534920.

2: Su L, Xu Q, Zhang P, Michalek SM, Katz J. The Phenotype and Function of Myeloid-derived Suppressor Cells Induced by Porphyromonas gingivalis Infection. Infect Immun. 2017 May 22. pii: IAI.00213-17. doi: 10.1128/IAI.00213-17. [Epub ahead of print] PubMed PMID: 28533469.

3: Patlaka C, Mira Pascual L, Paulie S, Henriksson AF, Arner P, Lång P, Andersson G. The Adipokine Tartrate Resistant Acid Phosphatase 5a in Serum Correlates to Adipose Tissue Expansion in Obesity. Biomarkers. 2017 May 22:1-34. doi: 10.1080/1354750X.2017.1334155. [Epub ahead of print] PubMed PMID: 28532220.

4: Wong KC, Cao S, Dong X, Law MC, Chan TH, Wong MS. (-)-Epiafzelechin Protects against Ovariectomy-induced Bone Loss in Adult Mice and Modulate Osteoblastic and Osteoclastic Functions In Vitro. Nutrients. 2017 May 22;9(5). pii: E530. doi: 10.3390/nu9050530. PubMed PMID: 28531166.

5: Publicover EA, Kolwich J, Stack DL, Doué AJ, Ylijoki KEO. Crystal structure of (S)-sec-butyl-ammonium l-tartrate monohydrate. Acta Crystallogr E Crystallogr Commun. 2017 Apr 18;73(Pt 5):716-719. doi: 10.1107/S2056989017005448. eCollection 2017 May 1. PubMed PMID: 28529783; PubMed Central PMCID: PMC5418791.

6: Lu B, Jiao Y, Wang Y, Dong J, Wei M, Cui B, Sun Y, Wang L, Zhang B, Chen Z, Zhao Y. A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis. Exp Mol Med. 2017 May 19;49(5):e336. doi: 10.1038/emm.2017.64. PubMed PMID: 28524179.

7: Vesprey A, Yang W. Pit Assay to Measure the Bone Resorptive Activity of Bone Marrow-derived Osteoclasts. Bio Protoc. 2016 Jun 20;6(12). pii: e1836. doi: 10.21769/BioProtoc.1836. PubMed PMID: 28516113; PubMed Central PMCID: PMC5431589.

8: Lin CJ, Su CW, Chen HS, Chen WL, Lin JM, Tsai YY. Rescue vitrectomy with blocked artery massage and bloodletting for branch retinal artery occlusion. Indian J Ophthalmol. 2017 Apr;65(4):323-325. doi: 10.4103/ijo.IJO_698_16. PubMed PMID: 28513500.

9: Wang C, Wang P, Liu X, Fu J, Xue K, Xu K. Novel enantioselective fluorescent sensors for tartrate anion based on acridinezswsxa. Luminescence. 2017 May 17. doi: 10.1002/bio.3327. [Epub ahead of print] PubMed PMID: 28512780.

10: Ding L, Li J, Liu W, Zuo Q, Liang SX. Influence of Nano-Hydroxyapatite on the Metal Bioavailability, Plant Metal Accumulation and Root Exudates of Ryegrass for Phytoremediation in Lead-Polluted Soil. Int J Environ Res Public Health. 2017 May 16;14(5). pii: E532. doi: 10.3390/ijerph14050532. PubMed PMID: 28509844.

11: Mizoue S, Nitta K, Shirakashi M, Nitta A, Yamabayashi S, Kimura T, Ueda T, Takeda R, Matsumoto S, Yoshikawa K. Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma. Adv Ther. 2017 May 15. doi: 10.1007/s12325-017-0552-5. [Epub ahead of print] PubMed PMID: 28508306.

12: Kim YM, Shin DH, Park SB, Cheon CK, Yoo HW. Case report of unexpected gastrointestinal involvement in type 1 Gaucher disease: comparison of eliglustat tartrate treatment and enzyme replacement therapy. BMC Med Genet. 2017 May 15;18(1):55. doi: 10.1186/s12881-017-0403-x. PubMed PMID: 28506293; PubMed Central PMCID: PMC5433137.

13: Ledesma-Colunga MG, Adán N, Ortiz G, Solís-Gutiérrez M, López-Barrera F, Martínez de la Escalera G, Clapp C. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis. Arthritis Res Ther. 2017 May 15;19(1):93. doi: 10.1186/s13075-017-1290-4. PubMed PMID: 28506283; PubMed Central PMCID: PMC5433139.

14: Kim M, Kim J, Jeong SW, Jo H, Woo YR, Park HJ. Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel. Exp Dermatol. 2017 May 13. doi: 10.1111/exd.13381. [Epub ahead of print] PubMed PMID: 28500634.

15: Kasturi S, Surarapu S, Uppalanchi S, Anireddy JS, Dwivedi S, Anantaraju HS, Perumal Y, Sigalapalli DK, Babu BN, Ethiraj KS. Synthesis and α-glucosidase inhibition activity of dihydroxy pyrrolidines. Bioorg Med Chem Lett. 2017 May 2. pii: S0960-894X(17)30451-1. doi: 10.1016/j.bmcl.2017.04.078. [Epub ahead of print] PubMed PMID: 28495082.

16: Feng Y, Liu Y, Xue L, Sun H, Guo Z, Zhang Y, Yang L. Carboxylic acid functionalized sesame straw: A sustainable cost-effective bioadsorbent with superior dye adsorption capacity. Bioresour Technol. 2017 Apr 21;238:675-683. doi: 10.1016/j.biortech.2017.04.066. [Epub ahead of print] PubMed PMID: 28494410.

17: Suwanwela J, Puangchaipruk D, Wattanasirmkit K, Kamolratanakul P, Jansisyanont P. Maxillary Sinus Floor Augmentation Using Xenograft: Gene Expression and Histologic Analysis. Int J Oral Maxillofac Implants. 2017 May/Jun;32(3):611-616. doi: 10.11607/jomi.5052. PubMed PMID: 28494043.

18: Marton N, Kovács OT, Baricza E, Kittel Á, Győri D, Mócsai A, Meier FMP, Goodyear CS, McInnes IB, Buzás EI, Nagy G. Extracellular vesicles regulate the human osteoclastogenesis: divergent roles in discrete inflammatory arthropathies. Cell Mol Life Sci. 2017 May 10. doi: 10.1007/s00018-017-2535-8. [Epub ahead of print] PubMed PMID: 28493076.

19: Spirlandeli AL, Dick-de-Paula I, Zamarioli A, Jorgetti V, Ramalho LNZ, Nogueira-Barbosa MH, Volpon JB, Jordão AA, Cunha FQ, Fukada SY, de Paula FJA. Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. Clinics (Sao Paulo). 2017 Apr;72(4):231-237. doi: 10.6061/clinics/2017(04)07. PubMed PMID: 28492723; PubMed Central PMCID: PMC5401620.

20: Yan YY, Zhang QA, Li EC, Zhang YF. Ions in Wine and Their Relation to Electrical Conductivity Under Ultrasound Irradiation. J AOAC Int. 2017 May 11. doi: 10.5740/jaoacint.17-0024. [Epub ahead of print] PubMed PMID: 28492135.